Gary A Lyons insider trades

Open-market stock purchases and sales by Gary A Lyons, Unknown at Travere Therapeutics, Inc, from SEC Form 4 filings since Apr 20, 2010.

Recent trades

DateStockTradeValue
Aug 18, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Aug 18, 2026TVTX Travere Therapeutics, IncSold$259K
Aug 18, 2026TVTX Travere Therapeutics, IncSold$57.5K
Aug 17, 2026TVTX Travere Therapeutics, IncSold$119K
Aug 17, 2026TVTX Travere Therapeutics, IncSold$165K
Aug 17, 2026TVTX Travere Therapeutics, IncSold$32.1K
Aug 17, 2026TVTX Travere Therapeutics, IncBought (not open market)—
May 27, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
May 27, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
May 21, 2026NBIX Neurocrine Biosciences IncBought (not open market)—
May 19, 2026TVTX Travere Therapeutics, IncBought (not open market)—
May 19, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Apr 14, 2026TVTX Travere Therapeutics, IncSold$329K
Apr 14, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Dec 3, 2025NBIX Neurocrine Biosciences IncSold$2.3M
Dec 3, 2025NBIX Neurocrine Biosciences IncBought (not open market)—

Companies traded

  • TVTX Travere Therapeutics, Inc: 8 sales, last Aug 18, 2026
  • NBIX Neurocrine Biosciences Inc: 27 sales, last May 27, 2026
  • RIGL Rigel Pharmaceuticals Inc: other filings, last May 26, 2023
  • ELDN Eledon Pharmaceuticals, Inc: other filings, last May 1, 2023
  • BBI Brickell Biotech, Inc: other filings, last May 17, 2022
  • NVUS Novus Therapeutics, Inc: other filings, last Sep 11, 2020
  • RTRX Retrophin, Inc: other filings, last May 15, 2020
  • VICL Vical Inc: 5 buys, 1 sale, last May 23, 2018
  • CTYX Cytori Therapeutics, Inc: other filings, last Nov 28, 2017
  • CYTX Cytori Therapeutics, Inc: other filings, last Jun 15, 2016
  • KBIO Kalobios Pharmaceuticals Inc: other filings, last Jul 10, 2015
  • NGSX NeurogesX Inc: other filings, last Jun 7, 2012

Get free alerts when Gary A Lyons files a new trade →